Related Experiment Video

Updated: Aug 8, 2026

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells
13:20

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells

Published on: July 30, 2010

Activation of the human p27(Kip1) promoter by IFNalpha 2b

A Moro1, A Santos, M J Araña

  • 1Division of Cell Biology, Centro de Ingeniería Genética y Biotecnología, Havana, C.P. 10600, Cuba. alejandro.moro@cigb.edu.cu

Biochemical and Biophysical Research Communications
|March 1, 2000
PubMed

Insights

Interferon alpha 2b (IFNalpha 2b) directly activates the human p27(Kip1) promoter, a key cell cycle regulator. This activation, observed in H82 cells, may involve specific binding sites within the promoter region.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Immunology

Background:

  • p27(Kip1) is a crucial cell cycle inhibitor, regulating cell proliferation by suppressing cyclin/cyclin-dependent kinase (CDK) activity.
  • p27(Kip1) expression is primarily controlled post-translationally, but its mRNA can be induced by factors like vitamin D3 and during neuronal differentiation.
  • The human p27(Kip1) gene promoter has recently been isolated and sequenced.

Purpose of the Study:

  • To investigate the effect of Interferon alpha 2b (IFNalpha 2b) on the human p27(Kip1) promoter activity.
  • To determine if IFNalpha 2b directly activates the p27(Kip1) promoter.

Main Methods:

  • Utilized transient expression assays in H82 cells.
  • Employed a luciferase reporter gene system driven by the human p27(Kip1) promoter.

Main Results:

  • IFNalpha 2b demonstrated activation of the human p27(Kip1) promoter-driven luciferase reporter gene.
  • The observed induction suggests a potential role for two IRF 1-like binding sites within the p27(Kip1) promoter in mediating this activation.

Conclusions:

  • IFNalpha 2b directly activates the human p27(Kip1) promoter.
  • This finding represents the first report of direct promoter activation by IFNalpha 2b and suggests a novel regulatory mechanism for p27(Kip1) expression.

More Related Videos

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...